Effect of vigabatrin on the pharmacokinetics of carbamazepine

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 6, 2002, Pages 427-430

  Sánchez Alcaraz, Agustín ^a   Quintana, Ma B ^a   Lopez E ^b   Rodriguez I ^b   Llopis, P ^a  

^a HOSPITAL DE LA RIBERA   (Spain)

^b HOSPITAL LLUÍS ALCANYÍS   (Spain)

Author keywords

Carbamazepine; Interactions; Plasma concentrations; Vigabatrine

Indexed keywords

CARBAMAZEPINE; VIGABATRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOCAL EPILEPSY; HUMAN; MALE; PLASMA CLEARANCE; STATISTICAL SIGNIFICANCE; STEADY STATE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; VIGABATRIN;

EID: 0036455917     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00441.x     Document Type: Article

References (8)

1. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia, 181, 1-10.
2. Perucca E. (1995) Pharmacological principles as a basis for polytherapy. Acta Neurologia Scandinavica, 92(Sup-pl.), 31-34.
3. Goldsmith P, De Bittencourt PRM. (1995) Rationalized polytherapy for epilepsy. Acta Neurologia Scandinavica, 92(Suppl.), 35-39.
4. Sánchez-Alcaraz A, Quintana B, Rodriguez I, López E. (1996) Plasma concentrations of vigabatrin in epileptic patients. Journal of Clinical Pharmacy and Therapeutics, 21, 393-398.
5. Rimmer EM, Richens A. (1989) Interaction between vigabatrin and phenytoin. British Journal of Clinical Pharmacolgy, 27(Suppl. 1), 27S-34S.
6. Gatti G, Bartoli A, Marchiselli R. (1993) Vigabatrin induced decrease in phenytoin concentration does not involve a change in phenytoin bioavailability. British Journal of Clinical Pharmacolgy, 36(Suppl. 6), 603-606.
7. Ferriols F, Ferriols R, Rodilla F, Ezquer J. (1996) Influence of vigabatrin on the pharmacokinetic parameters of valproic acid. European Hospital Pharmacy (E.H.P.), 2, 33-35.
8. Rey E, Pons G, Olive G. (1992) Vigabatrin. Clinical pharmacokinetics. Clinical Pharmacokinetics, 23, 267-278.